Fibromuscular dysplasia natural history, complications and prognosis: Difference between revisions
| Line 33: | Line 33: | ||
===Natural History=== | ===Natural History=== | ||
The most common clinical presentation of FMD is hypertension in women with the prime of their life, whereas FMD can occur in both genders at any age. | The most common clinical presentation of FMD is hypertension in women with the prime of their life, whereas FMD can occur in both genders at any age its presentations across the lifespan. | ||
In general, the clinical presentations of FMD in women as compared with men are somewhat different. manifestations of [[cerebrovascular]] FMD are more likely to occur in women, whereas manifestations of renal FMD, [[arterial dissection]]s and [[aneurysm]]s are more common in men.<ref>{{Cite journal | In general, the clinical presentations of FMD in women as compared with men are somewhat different. manifestations of [[cerebrovascular]] FMD are more likely to occur in women, whereas manifestations of renal FMD, [[arterial dissection]]s and [[aneurysm]]s are more common in men.<ref>{{Cite journal | ||
| author = [[Esther S. H. Kim]], [[Jeffrey W. Olin]], [[James B. Froehlich]], [[Xiaokui Gu]], [[J. Michael Bacharach]], [[Bruce H. Gray]], [[Michael R. Jaff]], [[Barry T. Katzen]], [[Eva Kline-Rogers]], [[Pamela D. Mace]], [[Alan H. Matsumoto]], [[Robert D. McBane]], [[Christopher J. White]] & [[Heather L. Gornik]] | | author = [[Esther S. H. Kim]], [[Jeffrey W. Olin]], [[James B. Froehlich]], [[Xiaokui Gu]], [[J. Michael Bacharach]], [[Bruce H. Gray]], [[Michael R. Jaff]], [[Barry T. Katzen]], [[Eva Kline-Rogers]], [[Pamela D. Mace]], [[Alan H. Matsumoto]], [[Robert D. McBane]], [[Christopher J. White]] & [[Heather L. Gornik]] | ||
| Line 47: | Line 47: | ||
}}</ref> | }}</ref> | ||
The most common presenting symptoms in 615 individuals from the United | The most common presenting symptoms in 615 individuals from the United | ||
States FMD Registry are as follows | States FMD Registry are as follows: | ||
*Headache | |||
*Pulsatile tinnitus | |||
*Neck pain | |||
*Flank or abdominal pain | |||
The most common presenting signs of FMD are as follows: | |||
●Hypertension – 67 percent (66 percent of women and 74 percent of men) | |||
●Cervical bruit – 25 percent (27 percent of women and 4 percent of men) | |||
●Abdominal bruit – 11 percent (12 percent of women and no men) | |||
Transient ischemic attack – 10 percent (10 percent of women and 4 percent | |||
of men) | |||
● | |||
●Stroke – 8 percent (8 percent of women and 4 percent of men) | |||
===Complications=== | ===Complications=== | ||
Revision as of 02:25, 13 June 2018
|
Fibromuscular dysplasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
ASA/ACCF/AHA Guideline Recommendations |
|
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
|
Case Studies |
|
Fibromuscular dysplasia natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Fibromuscular dysplasia natural history, complications and prognosis |
|
FDA on Fibromuscular dysplasia natural history, complications and prognosis |
|
CDC on Fibromuscular dysplasia natural history, complications and prognosis |
|
Fibromuscular dysplasia natural history, complications and prognosis in the news |
|
Blogs on Fibromuscular dysplasia natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Since Fibromuscular dysplasia can involve virtually every artery of the body, thus the clinical presentations of FMD vary widely and are determined by the vessels territories that are involved. in the FMD, multivessel involvement is common,then numerous and various manifestation may present. The clinical presentations of FMD may result from the stenosis, ischemia, dissection and occlusion,rupture of aneurysms and embolization of intravascular thrombi from dissection or aneurysms.[1][2]
Natural History, Complications, and Prognosis
Natural History
The most common clinical presentation of FMD is hypertension in women with the prime of their life, whereas FMD can occur in both genders at any age its presentations across the lifespan. In general, the clinical presentations of FMD in women as compared with men are somewhat different. manifestations of cerebrovascular FMD are more likely to occur in women, whereas manifestations of renal FMD, arterial dissections and aneurysms are more common in men.[3] The most common presenting symptoms in 615 individuals from the United States FMD Registry are as follows:
- Headache
- Pulsatile tinnitus
- Neck pain
- Flank or abdominal pain
The most common presenting signs of FMD are as follows: ●Hypertension – 67 percent (66 percent of women and 74 percent of men) ●Cervical bruit – 25 percent (27 percent of women and 4 percent of men) ●Abdominal bruit – 11 percent (12 percent of women and no men) Transient ischemic attack – 10 percent (10 percent of women and 4 percent of men) ● ●Stroke – 8 percent (8 percent of women and 4 percent of men)
Complications
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Jeffrey W. Olin & Brett A. Sealove (2011). "Diagnosis, management, and future developments of fibromuscular dysplasia". Journal of vascular surgery. 53 (3): 826–836. doi:10.1016/j.jvs.2010.10.066. PMID 021236620. Unknown parameter
|month=ignored (help) - ↑ Jeffrey W. Olin, Heather L. Gornik, J. Michael Bacharach, Jose Biller, Lawrence J. Fine, Bruce H. Gray, William A. Gray, Rishi Gupta, Naomi M. Hamburg, Barry T. Katzen, Robert A. Lookstein, Alan B. Lumsden, Jane W. Newburger, Tatjana Rundek, C. John Sperati & James C. Stanley (2014). "Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association". Circulation. 129 (9): 1048–1078. doi:10.1161/01.cir.0000442577.96802.8c. PMID 24548843. Unknown parameter
|month=ignored (help) - ↑ Esther S. H. Kim, Jeffrey W. Olin, James B. Froehlich, Xiaokui Gu, J. Michael Bacharach, Bruce H. Gray, Michael R. Jaff, Barry T. Katzen, Eva Kline-Rogers, Pamela D. Mace, Alan H. Matsumoto, Robert D. McBane, Christopher J. White & Heather L. Gornik (2013). "Clinical manifestations of fibromuscular dysplasia vary by patient sex: a report of the United States registry for fibromuscular dysplasia". Journal of the American College of Cardiology. 62 (21): 2026–2028. doi:10.1016/j.jacc.2013.07.038. PMID 23954333. Unknown parameter
|month=ignored (help)